GO
Loading...

Heart Risks & Glaxo's Avandia

Monday, 22 Feb 2010 | 8:32 AM ET

Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial 2007 study identifying heart risks in GlaxoSmithKline's Avandia diabetes drug. He talks to CNBC's Mike Huckman.